« previous next »
Pages: [1]

Author Topic: COVID-19 vaccine seroconversion in patients w/MS on ocrelizumab  (Read 35 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
COVID-19 vaccine seroconversion in patients w/MS on ocrelizumab
« on: December 13, 2022, 03:12:39 pm »

From New England Journal of Medicine Journal Watch (December 14, 2022)--"SARS-CoV-2 vaccine seroconversion in patients with MS on ocrelizumab" (in the "Summary and Comment" section):


https://bit.ly/3hs1Ziw
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics